Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

US Patent 10899748 · Granted Jan 26, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Method for treatment of a viral-mediated infectious disease2025
Polymer conjugated thyrointegrin antagonists2023
Composition and method for dual targeting in treatment of neuroendocrine tumors2022
Composition of scalable thyrointegrin antagonists with improved retention in tum2021
Environmentally natural protective and therapeutic (ENPT) face mask2021
Composition and method for dual targeting in treatment of neuroendocrine tumors2021
Method and composition for treating upper respiratory tract inflammatory and inf2021
Composition of scalable thyrointegrin antagonists with improved blood brain barr2021